Using a systematic approach we:
- Novel chemo-enzymatic roots to small molecule pharmaceuticals
- Synthesise intermediates for use in bioprocess optimisation
- Monitor, identify and overcome biosynthetic process rate limitations
- Efficiently recover and purify fully active target molecules
— Dr John Runnacles, Business Research Director,“We value our multi-year relationship with Ingenza, who have shown great capability and flexibility to help us successfully progress our technology development programme.”
Mitsubishi Chemical Methacrylates